Markets · 1 sources covering this

Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress

Qiagen NV has appointed Jonathan Pratt as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·2h ago
Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress
Qiagen NV has appointed Jonathan Pratt as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/b8c5c03826ad580e10272d95f95087dceaa942b0"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress"></iframe>

Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress

How 1 sources are covering this

Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress

More from Markets

NYU's Suzy Welch on Career Ambition & Gen Z's Work Paradox

U.S. automakers and home builders are among the big losers as Trump launches a trade war against Canada

German Finance Chief Says Trump Is to Blame for Surging Yields

Think Medicare Advantage provides better care for chronic conditions? A new study suggests otherwise.

Reader

Trust & legal

Across the network